Cymbalta Eases Back Pain In Study

Mon Aug 25, 2008

NEW YORK (Reuters) – Eli Lilly and Co’s Cymbalta depression treatment significantly reduced chronic low back pain in a relatively small clinical trial, the company said on Monday.

Data from the 236-patient trial, which lasted 13 weeks and compared the effectiveness of Cymbalta with placebos, were presented at the annual congress of the European Federation of Neurological Societies in Madrid. More…